The Clinical Study of Omics with Plasma and Urine in Chronic Heart Failure Patients: The Investigation with Peripheral Blood

The Clinical Study of Omics with Plasma and Urine in Chronic Heart Failure Patients: The Investigation with Peripheral Blood - The Clinical Study of Omics with Plasma and Urine in CHF Patients: The Investigation with Peripheral Blood

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036328

Enrollment

1000

Registered

2019-04-01

Start date

2016-09-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with or at high risk of chronic heart failure those attending Department of Cardiovascular Medicine, Tohoku University Hospital.

Exclusion criteria

Exclusion criteria: Patients who were judged to be not eligible in the present study by the physician in charge.

Design outcomes

Primary

Measure	Time frame
Genetic rare variant, single nucleotide polymorphism, metabolite, protein, and micro RNA.	—

Secondary

Measure	Time frame
Clinical information (sex, age, height, body weight, blood pressure, heart rate, SAS, NYHA class, HF stage class, heart disease, echocardiogram, blood test, urine test, chest X-ray, electrocardiogram, drug allergy, past history, smoking, drinking, family history).	—

Countries

Japan

Contacts

Public ContactYasuhiko Sakata

Tohoku University Graduate School of Medicine Department of Cardiovascular Medicine

sakatayk@cardio.med.tohoku.ac.jp022(717)7153

Outcome results